Literature DB >> 11845012

Epidemiology of psoriatic arthritis.

William J Taylor1.   

Abstract

Research into psoriatic arthritis continues to be hampered by the lack of a validated case-definition. There may be progress toward consensus with a new data-derived diagnostic classification criteria set recently reported and a current international project aiming to firmly validate criteria. Statistical techniques such as latent class analysis may permit a comparison of the accuracy of competing criteria sets, in the absence of a gold standard for diagnosis. Genetic studies are inconclusive, but ethnic differences in disease expression suggest a definite genetic role. Recent community-based research suggests an incidence rate of about 6/100,000 per annum, and a prevalence of about 1/1000. Clinic-based disease may be associated with increased mortality, whereas community based disease is not. The development of internationally accepted criteria for the diagnosis of psoriatic arthritis will be a major impetus towards research into this complex disease.

Entities:  

Mesh:

Year:  2002        PMID: 11845012     DOI: 10.1097/00002281-200203000-00004

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  9 in total

1.  The burden of psoriatic arthritis: a literature review from a global health systems perspective.

Authors:  Seina Lee; Alan Mendelsohn; Evelyn Sarnes
Journal:  P T       Date:  2010-12

2.  Clinical features and types of articular involvement in patients with psoriatic arthritis.

Authors:  Salim Dönmez; Ömer Nuri Pamuk; Mustafa Akker; Recep Ak
Journal:  Clin Rheumatol       Date:  2014-07-29       Impact factor: 2.980

3.  The prevalences of some rheumatic diseases in western Turkey: Havsa study.

Authors:  Necati Cakır; Ömer Nuri Pamuk; Emine Derviş; Neşe Imeryüz; Haşim Uslu; Ömer Benian; Edip Elelçi; Genco Erdem; Fatma Oğuz Sarvan; Mustafa Senocak
Journal:  Rheumatol Int       Date:  2011-01-13       Impact factor: 2.631

4.  Deletion of late cornified envelope genes, LCE3C_LCE3B-del, is not associated with psoriatic arthritis in Tunisian patients.

Authors:  Bouchlaka Souissi Chiraz; Ammar Myriam; Zarra Ines; Jordan Catherine; Bouazizi Fatma; Cheour Ilhem; Tekaya Raoudha; Zeglaoui Hela; Fourati Hela; Bouajina Elyes; Doss Nejib; Helms Cindy; Elgaaied Amel; Sellami Slaheddine
Journal:  Mol Biol Rep       Date:  2014-02-25       Impact factor: 2.316

Review 5.  Preliminary identification of core domains for outcome studies in psoriatic arthritis using Delphi methods.

Authors:  W J Taylor
Journal:  Ann Rheum Dis       Date:  2005-03       Impact factor: 19.103

6.  [Psoriasis und Psoriasis arthritis in childhood and adolescence. Overview and consensus statement of the 9th Wörlitz Expert Round Table Discussion 2006 for the Society for Child and Adolescent Rheumatology].

Authors:  M Sticherling; K Minden; R-M Küster; A Krause; M Borte
Journal:  Z Rheumatol       Date:  2007-07       Impact factor: 1.372

7.  Infliximab in the treatment of plaque type psoriasis.

Authors:  Rosita Saraceno; Andrea Saggini; Lucia Pietroleonardo; Sergio Chimenti
Journal:  Clin Cosmet Investig Dermatol       Date:  2009-04-03

8.  Developing a diagnostic checklist of traditional Chinese medicine symptoms and signs for psoriasis: a Delphi study.

Authors:  Xuesong Yang; Virasakdi Chongsuvivatwong; Edward McNeil; Jianzhou Ye; Xiaoyong Ouyang; Enpin Yang; Hutcha Sriplung
Journal:  Chin Med       Date:  2013-05-12       Impact factor: 5.455

9.  MiR-146a G/C rs2910164 variation in South African Indian and Caucasian patients with psoriatic arthritis.

Authors:  Ajesh B Maharaj; Pragalathan Naidoo; Terisha Ghazi; Naeem S Abdul; Shanel Dhani; Taskeen F Docrat; Prithiksha Ramkaran; Paul-Peter Tak; Niek de Vries; Anil A Chuturgoon
Journal:  BMC Med Genet       Date:  2018-03-27       Impact factor: 2.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.